Clinical Data Standards

2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards

Endorsed by the Heart Failure Society of America and Society for Cardiac Angiography and Interventions

This document was approved by the American College of Cardiology Clinical Policy Approval Committee and the American Heart Association Science Advisory and Coordinating Committee in February 2022, and the American Heart Association Executive Committee in April 2022.

The American College of Cardiology requests that this document be cited as follows: Bozkurt B, Das SR, Addison D, Gupta A, Jneid H, Khan SS, Koromia GA, Kulkarni PA, LaPoint K, Lewis EF, Michos ED, Peterson PN, Turagam MK, Wang TY, Yancy CW. 2022 AHA/ACC key data elements and definitions for cardiovascular and noncardiovascular complications of COVID-19: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol. 2022;80:388–465.

This article is copublished in Circulation: Cardiovascular Quality and Outcomes.

Copies: This document is available on the websites of the American College of Cardiology (https://www.acc.org) and the American Heart Association (https://professional.heart.org). For copies of this document, please contact Elsevier Inc. Reprint Department, fax 212-633-3820, email [email protected].

Permissions: Multiple copies, modification, alteration, enhancement, and/ or distribution of this document are not permitted without the express permission of the American College of Cardiology. Instructions for obtaining permission are located at https://www.elsevier.com/about/policies/copyright/permissions.

Task Force Liaison.

ACC/AHA staff.

Former Task Force member; current member during the writing effort.